HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

INNOVENT BIO

78.400

+1.0501.36%

Volume:27.80M

Turnover:2.16B

Market Cap:129.60B

PE:-1.23K

High:80.800

Open:78.800

Low:75.600

Close:77.350

Loading ...

Overview Company News Filings

China's Innogen expects to complete weight-loss drug trials next year

World's First Dual GCG/GLP-1 Receptor Agonist for Obesity Approved in China, Delivered via Ypsomed Autoinjector

Innovent Biologics Announces New Share Options and Restricted Shares Plan for Employees

Innovent Biologics's Weight-Loss Drug Could Start to Generate Revenue This Year -- Market Talk

Innovent Biologics Inc. Highlights Dual Innovations at Oncology R&D Day, Pioneering Future Cancer Treatments

Innovent Biologics -Co's Dual Gcg/Glp-1 Receptor Agonist Mazdutide Receives Nmpa Approval for Chronic Weight Management in China

THOMSON REUTERS

China's medical products regulator approves Innovent Biologics's weight control injection

China Medical Products Administration: Approves Innovent Bio's Weight Control Peptide Injection

THOMSON REUTERS

Chinese Companies Line Up Nearly $2.0 Billion of Fundraising

BRIEF-Innovent Biologics To Place 55 Million Placing Shares

Innovent Biologics - to Place 55 Mln Placing Shares at Price on Terms and Subject to Conditions Set Out in Placing Agreement

THOMSON REUTERS

Innovent Biologics - Gross Proceeds From Placing Expected to Be HK$4,309.8 Mln

THOMSON REUTERS

Innovent Biologics Inc. Conducted Annual General Meeting

Innovent Biologics' Mazdutide NDA for Glycemic Control in T2D Under Review by China's NMPA

Innovent Announces the Phase 3 Clinical Study Dreams-1 of Mazdutide in China Were Orally Presented at Ada 85TH Scientific Sessions

THOMSON REUTERS

Innovent Biologics Unveils Promising Preclinical Study Results for Novel Antibody-Peptide Conjugate Targeting Cardiovascular Risk Markers at ADA Conference

Innovent Biologics Launches Seventh Phase 3 Clinical Trial of Mazdutide for Obstructive Sleep Apnea and Obesity in China

Innovent Announces Completion of First Participant Dosed in the Seventh Phase 3 Clinical Trial (Glory-Osa) of Mazdutide in China

THOMSON REUTERS

Innovent Biologics to Present Phase 3 Clinical Trial Results of Mazdutide for Type 2 Diabetes at ADA Scientific Sessions

BUZZ-Next-generation obesity drugs in focus at upcoming diabetes meeting, Berenberg says

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/01801/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01801","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01801\",,,,,undefined,":{"symbol":"01801","market":"HK","secType":"STK","nameCN":"INNOVENT BIO","latestPrice":78.4,"timestamp":1751270891013,"preClose":77.35,"halted":0,"volume":27799285,"delay":0,"floatShares":1653000000,"shares":1653000000,"eps":-0.06373698787179427,"marketStatus":"Closed Hong Kong Special Administrative Region Establishment Day","change":1.05,"latestTime":"06-30 16:08:11","open":78.8,"high":80.8,"low":75.6,"amount":2162431011,"amplitude":0.067227,"askPrice":78.4,"askSize":83500,"bidPrice":78.35,"bidSize":4000,"shortable":3,"etf":0,"ttmEps":-0.0657692579422085,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1751419800000},"marketStatusCode":7,"adr":0,"listingDate":1540915200000,"exchange":"SEHK","adjPreClose":77.35,"openAndCloseTimeList":[[1751247000000,1751256000000],[1751259600000,1751270400000]],"volumeRatio":1.001588473701527,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"INB.HK","impliedVol":0.6361,"impliedVolPercentile":0.7724},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01801\",,,,,undefined,":{"symbol":"01801","floatShares":1653000000,"roa":"-0.82%","roe":"-0.74%","lyrEps":-0.063737,"volumeRatio":1.001588473701527,"shares":1653000000,"dividePrice":0,"high":80.8,"amplitude":0.067227,"preClose":77.35,"low":75.6,"week52Low":28.65,"pbRate":"9.01","psRate":"12.55","week52High":83.8,"institutionHeld":0,"latestPrice":78.4,"committee":-0.908571,"eps":-0.06373698787179427,"divideRate":0,"volume":27799285,"delay":0,"ttmEps":-0.0657692579422085,"open":78.8,"prevYearClose":36.6,"prevWeekClose":77.35,"prevMonthClose":78.4,"prevQuarterClose":78.4,"fiveDayClose":78.9,"twentyDayClose":63.1,"sixtyDayClose":46.6},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01801\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2548000753","title":"China's Innogen expects to complete weight-loss drug trials next year","url":"https://stock-news.laohu8.com/highlight/detail?id=2548000753","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548000753?lang=en_us&edition=fundamental","pubTime":"2025-07-01 22:01","pubTimestamp":1751378481,"startTime":"0","endTime":"0","summary":"China's Innogen expects to complete weight-loss drug trials next yearInnogen's experimental drug approved for diabetes treatmentInnovent latest to secure China's approval for weight-loss drug More weight-loss drugs seen coming onto the market, analyst saysLocal competition in weight-loss drug market intensifying  By Andrew Silver","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nL6N3SY0DF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0466842654.USD","LU0471298694.HKD","SG9999014906.USD","LU0820561818.USD","IE00BFTCPJ56.SGD","LU2264538146.SGD","BK4581","LU2236285917.USD","LU0234572021.USD","SGXZ31699556.SGD","LU0417517546.SGD","BK1589","LU1280957306.USD","LU2023250504.SGD","LU0354030438.USD","LU0203202063.USD","LU1720051108.HKD","LU2324357040.USD","BK1161","LU1551013425.SGD","BK1583","LU0096364046.USD","IE00B1BXHZ80.USD","SG9999013999.USD","LU2357305700.SGD","SG9999001176.USD","01801","LU2417539215.USD","LU2106854487.HKD","LU0238689110.USD","LU2211815571.USD","LU0256863902.USD","LU0266013472.USD","LU0256863811.USD","LU0786609619.USD","LU0823416689.USD","LU1366192091.USD","LU0006306889.USD","LU2456880835.USD","LU2237443895.HKD","LU1868837136.USD","LU1291159041.SGD","LU2746668461.USD","SG9999015978.USD","SG9999018865.SGD","LU1804176565.USD","LU1093756168.USD","IE00B2B36J28.USD","LU0097036916.USD"],"gpt_icon":1},{"id":"2548802921","title":"World's First Dual GCG/GLP-1 Receptor Agonist for Obesity Approved in China, Delivered via Ypsomed Autoinjector","url":"https://stock-news.laohu8.com/highlight/detail?id=2548802921","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548802921?lang=en_us&edition=fundamental","pubTime":"2025-07-01 13:03","pubTimestamp":1751346207,"startTime":"0","endTime":"0","summary":"Ypsomed Holding AG has announced the regulatory approval of Mazdutide, the world's first dual GCG/GLP-1 receptor agonist drug for the treatment of obesity, by the Chinese National Medical Products Administration . This groundbreaking therapy, developed by Innovent Biologics, Inc., will be delivered using Ypsomed's YpsoMate 1.0 autoinjector. The approval marks a significant milestone in obesity treatment, emphasizing Ypsomed's strategic \"China for China\" approach aimed at strengthening supply chain resilience and ensuring proximity to the Chinese market. The collaboration between Ypsomed and Innovent Biologics has been established since 2019, highlighting both companies' commitment to innovation and accessible healthcare solutions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nNDL4r1Hn1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","LU2488822045.USD","LU1969619763.USD","01911","BK1161","LU2328871848.SGD","BK1583","BK1147","01801"],"gpt_icon":0},{"id":"2547091318","title":"Innovent Biologics Announces New Share Options and Restricted Shares Plan for Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2547091318","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547091318?lang=en_us&edition=fundamental","pubTime":"2025-06-30 20:28","pubTimestamp":1751286521,"startTime":"0","endTime":"0","summary":"Innovent Biologics Inc. has announced a new compensation plan, effective June 30, 2025, under the 2024 Share Scheme. The company granted 35,000 share options to three grantees and 497,750 restricted shares to 25 grantees. These grants are contingent upon individual annual performance targets, which are aligned with specific functional benchmarks, such as research and development, CMC, and commercialization. Additionally, a clawback mechanism has been established, allowing the company to reclaim shares or cash if certain conditions are met, such as the grantee no longer being an eligible participant. The board, led by Chairman Dr. De-Chao Michael Yu, oversees the implementation of these new compensation terms.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investme","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nNDL1pLrJB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","BK1589","LU2488822045.USD","BK1161","01911","LU2328871848.SGD","LU1969619763.USD","BK1583","BK1147"],"gpt_icon":0},{"id":"2547062013","title":"Innovent Biologics's Weight-Loss Drug Could Start to Generate Revenue This Year -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2547062013","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547062013?lang=en_us&edition=fundamental","pubTime":"2025-06-30 17:47","pubTimestamp":1751276820,"startTime":"0","endTime":"0","summary":"0947 GMT - Innovent Biologics's newly approved weight-loss drug could begin to bring in revenue in 2H, Morningstar analyst Yurou Zheng says in a research note. Innovent secured approval last week in China for its weight-loss drug mazdutide. The analyst thinks the near-term challenge for mazdutide, or weight-loss drugs in general, is potential price competition. Users will likely pivot to cheaper options if the efficacy profiles are similar or even slightly less superior, the analyst says. \"Over the long term, a bigger challenge for the industry would be coming up with the next generation weight loss drug, especially for orally administered ones with an emphasis on the small molecule modality for greater effect,\" she adds.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801"],"gpt_icon":0},{"id":"2547058045","title":"Innovent Biologics Inc. Highlights Dual Innovations at Oncology R&D Day, Pioneering Future Cancer Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2547058045","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547058045?lang=en_us&edition=fundamental","pubTime":"2025-06-30 12:04","pubTimestamp":1751256297,"startTime":"0","endTime":"0","summary":"Innovent Biologics Inc. recently held its Oncology R&D Day, where it showcased its strategic focus on dual innovation in next-generation immuno-oncology  and antibody-drug conjugate  technologies. The event, attended by over 500 participants including leading oncology key opinion leaders, principal investigators, analysts, and global investors, highlighted Innovent's commitment to advancing cancer treatment standards and its vision of becoming a global premier biopharmaceutical leader.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Innovent Biologics Inc. published the original content used to generate this news brief via PR Newswire  on June 30, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nNDL8MxMjg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","LU2328871848.SGD","01801","LU2488822045.USD","BK1147","BK1161","LU1969619763.USD","01911","BK1583"],"gpt_icon":0},{"id":"2546790428","title":"Innovent Biologics -Co's Dual Gcg/Glp-1 Receptor Agonist Mazdutide Receives Nmpa Approval for Chronic Weight Management in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2546790428","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546790428?lang=en_us&edition=fundamental","pubTime":"2025-06-27 16:36","pubTimestamp":1751013379,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250627:nFWN3ST145:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1969619763.USD","LU2488822045.USD","BK1583","BK1161","BK1589","LU2328871848.SGD","01801"],"gpt_icon":0},{"id":"2546794710","title":"China's medical products regulator approves Innovent Biologics's weight control injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2546794710","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546794710?lang=en_us&edition=fundamental","pubTime":"2025-06-27 15:34","pubTimestamp":1751009679,"startTime":"0","endTime":"0","summary":"China's medical products regulator approves Innovent Biologics's weight control injectionBEIJING, June 27  - China's National Medical Products Administration has approved domestic drugmaker Innovent Biologics's 1801.HK weight control peptide injection's entry into the market, the regulator said in a statement on Friday.  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250627:nP8N3RM058:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1583","LU2328871848.SGD","LU2488822045.USD","LU1969619763.USD","BK1161","01801"],"gpt_icon":0},{"id":"2546948767","title":"China Medical Products Administration: Approves Innovent Bio's Weight Control Peptide Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2546948767","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546948767?lang=en_us&edition=fundamental","pubTime":"2025-06-27 15:34","pubTimestamp":1751009678,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250627:nP8N3RM058:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1969619763.USD","LU2488822045.USD","BK1161","LU2328871848.SGD","BK1589","01801","BK1583"],"gpt_icon":0},{"id":"2546727769","title":"Chinese Companies Line Up Nearly $2.0 Billion of Fundraising","url":"https://stock-news.laohu8.com/highlight/detail?id=2546727769","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546727769?lang=en_us&edition=fundamental","pubTime":"2025-06-26 12:42","pubTimestamp":1750912920,"startTime":"0","endTime":"0","summary":"Three Chinese companies, including a logistics services provider and a drug maker, have announced plans to raise nearly $2 billion of funds, signaling renewed confidence to tap investors' growing risk appetite.Chinese express delivery firm S.F.Holding plans to raise 5.90 billion Hong Kong dollars, or about US$751.6 million, via a share placement and convertible bond issuance, it said in an exchange filing. The Shenzhen-based company plans to use the proceeds for business expansion, and to fund research and development.The company debuted in Hong Kong in late 2024, raising around HK$5.7 billion in the city's second-largest listing of that year. It is also listed in Shenzhen.Innovent Biologics, one of China's leading biotech companies, plans to raise HK$4.31 billion in gross proceeds by placing 55.0 million shares. It aims to use the funds for general corporate purposes.Meanwhile, ZhongAn Online P&C Insurance, based in Shanghai, aims to raise HK$3.92 billion in gross proceeds via share p","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","IE0003795394.USD","BK0232","BK0028","IE0003851619.USD","BK1589","BK0196","BK1619","LU1781817850.SGD","06060","IE00BYTNYN87.SGD","BK1161","BK1516","IE00B12V2V27.USD","IE00BYQNZ168.SGD","BK1136","BK0187","BK1550","01801","LU2488822045.USD","BK1571","LU0405327494.USD","002352","LU0405327148.USD","LU1969619763.USD","LU2328871848.SGD","BK0197","BK1127","LU1580142542.USD"],"gpt_icon":1},{"id":"2546220045","title":"BRIEF-Innovent Biologics To Place 55 Million Placing Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2546220045","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546220045?lang=en_us&edition=fundamental","pubTime":"2025-06-26 09:10","pubTimestamp":1750900227,"startTime":"0","endTime":"0","summary":"BRIEF-Innovent Biologics To Place 55 Million Placing SharesJune 26  - Innovent Biologics Inc 1801.HK:TO PLACE 55 MILLION PLACING SHARES AT PRICE ON TERMS AND SUBJECT TO CONDITIONS SET OUT IN PLACING AGREEMENTGROSS PROCEEDS FROM PLACING EXPECTED TO BE HK$4,309.8 MILLIONFurther company coverage: 1801.HK ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nFWN3SS0IR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","LU2488822045.USD","BK1583","BK1161","BK1589","LU2328871848.SGD","01801"],"gpt_icon":0},{"id":"2546073221","title":"Innovent Biologics - to Place 55 Mln Placing Shares at Price on Terms and Subject to Conditions Set Out in Placing Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2546073221","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546073221?lang=en_us&edition=fundamental","pubTime":"2025-06-26 07:01","pubTimestamp":1750892516,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250625:nFWN3SS0IR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1969619763.USD","BK1583","BK1161","BK1589","LU2328871848.SGD","01801","LU2488822045.USD"],"gpt_icon":0},{"id":"2546022102","title":"Innovent Biologics - Gross Proceeds From Placing Expected to Be HK$4,309.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2546022102","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546022102?lang=en_us&edition=fundamental","pubTime":"2025-06-26 07:01","pubTimestamp":1750892516,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250625:nFWN3SS0IR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2328871848.SGD","LU1969619763.USD","BK1583","BK1589","LU2488822045.USD","BK1161","01801"],"gpt_icon":0},{"id":"2546294934","title":"Innovent Biologics Inc. Conducted Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2546294934","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546294934?lang=en_us&edition=fundamental","pubTime":"2025-06-25 16:35","pubTimestamp":1750840512,"startTime":"0","endTime":"0","summary":"Innovent Biologics Inc. held its annual general meeting on June 25, 2025. During the meeting, a proposal to extend the general mandate granted to the Directors to issue shares by adding the total number of shares to be bought back was approved. Additionally, the grant of 2,754,000 restricted shares to Dr. De-Chao Michael Yu was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Innovent Biologics Inc. published the original content used to generate this news brief on June 25, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250625:nNDLbrqbMw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","BK1161","BK1589","BK1583","BK1147","LU1969619763.USD","LU2488822045.USD","LU2328871848.SGD","01911"],"gpt_icon":0},{"id":"2545233734","title":"Innovent Biologics' Mazdutide NDA for Glycemic Control in T2D Under Review by China's NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2545233734","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545233734?lang=en_us&edition=fundamental","pubTime":"2025-06-24 22:03","pubTimestamp":1750773794,"startTime":"0","endTime":"0","summary":"Innovent Biologics Inc., a leading biopharmaceutical company, announced that its New Drug Application  for mazdutide, a dual glucagon/glucagon-like peptide-1 receptor agonist, has been accepted for review by China's National Medical Products Administration . This regulatory review pertains to mazdutide's use in glycemic control for Chinese adults with type 2 diabetes. The Phase 3 DREAMS-1 clinical study demonstrated significant benefits in glycemic control, weight loss, and improvements in cardiovascular, renal, and metabolic indicators. Innovent Biologics anticipates that, upon approval, mazdutide will offer a superior treatment option for the vast number of type 2 diabetes patients in China.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal adv","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nNDL2kwKzy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU2328871848.SGD","BK1583","LU1969619763.USD","01911","LU2488822045.USD","BK1589","01801","BK1147"],"gpt_icon":0},{"id":"2545280233","title":"Innovent Announces the Phase 3 Clinical Study Dreams-1 of Mazdutide in China Were Orally Presented at Ada 85TH Scientific Sessions","url":"https://stock-news.laohu8.com/highlight/detail?id=2545280233","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545280233?lang=en_us&edition=fundamental","pubTime":"2025-06-24 22:02","pubTimestamp":1750773774,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nTUA8NDZSG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1589","BK1583","LU2488822045.USD","LU2328871848.SGD","LU1969619763.USD","BK1161","01801"],"gpt_icon":0},{"id":"2545438805","title":"Innovent Biologics Unveils Promising Preclinical Study Results for Novel Antibody-Peptide Conjugate Targeting Cardiovascular Risk Markers at ADA Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2545438805","media":"Reuters","labels":["productRelease","conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545438805?lang=en_us&edition=fundamental","pubTime":"2025-06-22 09:36","pubTimestamp":1750556184,"startTime":"0","endTime":"0","summary":"Innovent Biologics Unveils Promising Preclinical Study Results for Novel Antibody-Peptide Conjugate Targeting Cardiovascular Risk Markers at ADA Conference. Innovent Biologics Inc. is set to present multiple research findings from its biomedicine pipeline at the upcoming American Diabetes Association's  85th Scientific Sessions. Scheduled for June 22, 2025, the presentations will include exploratory mechanism-of-action analyses of mazdutide from investigator-initiated trials and a preclinical study of IBI3030, a novel PCSK9-GGG antibody-peptide conjugate. IBI3030 has shown promise in preclinical models for improving cardiovascular risk markers through its multi-target approach. The preclinical study results indicate significant reductions in LDL-c and Lp, improved glucose tolerance, weight reduction, and preserved insulin sensitivity. These findings will be showcased during a poster session at the ADA conference, highlighting Innovent's commitment to advancing next-generation therapies","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250622:nNDL95NyDN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1147","LU1969619763.USD","LU2488822045.USD","01911","BK1583","BK1589","LU2328871848.SGD","BK1161","01801"],"gpt_icon":0},{"id":"2543612965","title":"Innovent Biologics Launches Seventh Phase 3 Clinical Trial of Mazdutide for Obstructive Sleep Apnea and Obesity in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2543612965","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543612965?lang=en_us&edition=fundamental","pubTime":"2025-06-16 08:00","pubTimestamp":1750032027,"startTime":"0","endTime":"0","summary":"Innovent Biologics Inc. has announced the successful dosing of the first participant in the seventh Phase 3 clinical trial  of mazdutide in China. Mazdutide is a dual glucagon  and glucagon-like peptide-1  receptor agonist intended for Chinese participants with moderate-to-severe obstructive sleep apnea  and obesity. This trial aims to further explore the potential of mazdutide in managing obesity and a range of metabolic syndromes. Previous studies have shown promising results, with a Phase 2 study indicating an 18.6% weight loss compared to placebo. The results of the GLORY-OSA study are expected to be presented in the future, as the study progresses.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Innovent Biologics Inc. published th","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nNDL10ZJJM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","BK1589","LU1969619763.USD","01911","01801","BK1583","BK1161","LU2328871848.SGD","BK1147"],"gpt_icon":0},{"id":"2543612964","title":"Innovent Announces Completion of First Participant Dosed in the Seventh Phase 3 Clinical Trial (Glory-Osa) of Mazdutide in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2543612964","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543612964?lang=en_us&edition=fundamental","pubTime":"2025-06-16 08:00","pubTimestamp":1750032004,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nTUA981WKS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1589","LU2328871848.SGD","01801","LU2488822045.USD","BK1161","LU1969619763.USD","BK1583"],"gpt_icon":0},{"id":"2543152182","title":"Innovent Biologics to Present Phase 3 Clinical Trial Results of Mazdutide for Type 2 Diabetes at ADA Scientific Sessions","url":"https://stock-news.laohu8.com/highlight/detail?id=2543152182","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543152182?lang=en_us&edition=fundamental","pubTime":"2025-06-13 09:00","pubTimestamp":1749776424,"startTime":"0","endTime":"0","summary":"Innovent Biologics Inc., a leading biopharmaceutical company specializing in oncology, autoimmune, cardiovascular and metabolic, and ophthalmology treatments, has announced the upcoming presentation of multiple clinical study results at the American Diabetes Association's 85th Scientific Sessions in Chicago from June 20-23, 2025. Highlighting the event will be the oral presentation of the first Phase 3 study of mazdutide in Chinese adults with Type 2 Diabetes , known as DREAMS-1, scheduled for June 23. Additionally, numerous exploratory mechanism of action analyses of mazdutide and a preclinical study of the novel antibody-peptide conjugate IBI3030 will be featured in poster presentations on June 22. These presentations aim to further validate the differentiated profile of mazdutide as a next-generation GCG/GLP-1 dual receptor agonist.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and time","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250613:nNDL7Gws5d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","LU2328871848.SGD","01801","LU2488822045.USD","BK1147","BK1161","LU1969619763.USD","01911","BK1583"],"gpt_icon":0},{"id":"2542773813","title":"BUZZ-Next-generation obesity drugs in focus at upcoming diabetes meeting, Berenberg says","url":"https://stock-news.laohu8.com/highlight/detail?id=2542773813","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542773813?lang=en_us&edition=fundamental","pubTime":"2025-06-11 14:39","pubTimestamp":1749623992,"startTime":"0","endTime":"0","summary":"BUZZ-Next-generation obesity drugs in focus at upcoming diabetes meeting, Berenberg says** Berenberg analysts outline expectations for obesity drug updates during American Diabetes Association meeting on June 20-23** Investor interest in obesity stocks waned after Novo Nordisk's NOVOb.CO CagriSema disappointed, but event could revive it with new data - Berenberg** Adds, Eli Lilly's LLY.N orforglipron also in spotlight ** Detailed CagriSema data can highlight weight loss potential and other parameters that could help Novo move further off its lows, they say** YTD, NOVOb is down 16.7% ** Adds, if orforglipron confirmed safe, will increase investor confidence of a 2026 launch** Several companies to present data on amylin, and if positive, Berenberg expects a positive effect for Zealand ZELA.CO due to its high exposure** Data on Amgen's AMGN.O MariTide, Lilly's bimagrumab and Roche's ROG.S CT-388 are also on Berenberg's radar** It will also watch updates from BrightGene 688166.SS on BGM050","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nL4N3SE0E8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203202063.USD","LU2488822045.USD","LU2242652126.USD","LU2361044865.SGD","LU2361044949.HKD","SG9999014898.SGD","LU2461242641.AUD","LU2602419157.SGD","LU2462157665.USD","SG9999014880.SGD","IE0004445239.USD","LU0708995401.HKD","AMGN","LU0889565916.HKD","LU0786609619.USD","IE00BK4W5L77.USD","LU1035775433.USD","LU1868836591.USD","LU1989771016.USD","SGXZ51526630.SGD","LU2471134796.USD","LU1548497426.USD","LU0471298694.HKD","LU1974910355.USD","01801","LU2237443549.SGD","IE00BJT1NW94.SGD","LU0323591593.USD","LU0256863811.USD","LU1232071149.USD","LU2552382058.USD","LU2750360641.GBP","LU0640476718.USD","LU2750360997.AUD","LU1291159041.SGD","SG9999018857.SGD","LU1814569148.SGD","TERN","LU0006306889.USD","LU0256863902.USD","688166","LU1720051108.HKD","LLY","LU1093756168.USD","LU1057294990.SGD","LU2471134879.HKD","LU2023250504.SGD","LU2552382132.HKD","LU2237443622.USD","LU2211815571.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":85,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01801\",params:#limit:5,,,undefined,":[{"date":"2025-03-26","symbol":"01801","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742952600000,"name":null,"time":"Post Market","dateTimestamp":1742918400000,"actualEps":null},{"date":"2024-08-28","symbol":"01801","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724808600000,"name":null,"time":"","dateTimestamp":1724774400000,"actualEps":null},{"date":"2024-03-20","symbol":"01801","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1710898200000,"name":null,"time":"","dateTimestamp":1710864000000,"actualEps":null},{"date":"2023-08-23","symbol":"01801","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692754200000,"name":null,"time":"","dateTimestamp":1692720000000,"actualEps":null},{"date":"2023-03-28","symbol":"01801","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1679967000000,"name":null,"time":"","dateTimestamp":1679932800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01801\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01801\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3846,"buy":0.5385,"hold":0.0385,"sell":0.0385,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5385,"analysts":26,"updateTime":1743782400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01801\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01801","date":"2025-06-30","current":-1248.706528,"percent":0.009756,"low":-1314.719354,"twenty":-60.856179,"median":-43.894007,"eighty":-19.437399,"high":-7.531991,"avg":-89.473208,"sd":208.240962,"marketCap":129484340596},"quantilePoints":[{"date":"2020-07-03","current":-42.15165,"twenty":-31.212367,"median":-21.5439,"eighty":-5.426457,"marketCap":79513042032},{"date":"2020-07-10","current":-41.718218,"twenty":-33.055097,"median":-23.009394,"eighty":-5.428958,"marketCap":79445885746},{"date":"2020-07-17","current":-36.617176,"twenty":-33.853843,"median":-23.56045,"eighty":-5.435413,"marketCap":69842536920},{"date":"2020-07-24","current":-35.392158,"twenty":-34.117248,"median":-23.759204,"eighty":-5.43938,"marketCap":67241749424},{"date":"2020-07-31","current":-34.790809,"twenty":-34.526864,"median":-24.13478,"eighty":-5.448361,"marketCap":66487246107},{"date":"2020-08-07","current":-36.619021,"twenty":-34.926791,"median":-24.303633,"eighty":-5.465712,"marketCap":70056561424},{"date":"2020-08-14","current":-36.782836,"twenty":-35.235669,"median":-24.961961,"eighty":-5.472343,"marketCap":70546467448},{"date":"2020-08-21","current":-40.576246,"twenty":-35.792876,"median":-25.584933,"eighty":-5.486343,"marketCap":78175004107},{"date":"2020-08-28","current":-43.795492,"twenty":-36.439174,"median":-26.421678,"eighty":-5.520251,"marketCap":79784695329},{"date":"2020-09-04","current":-39.665739,"twenty":-36.777743,"median":-27.271989,"eighty":-5.526185,"marketCap":72506091544},{"date":"2020-09-11","current":-42.988967,"twenty":-37.537428,"median":-27.599103,"eighty":-5.541887,"marketCap":78664910131},{"date":"2020-09-18","current":-47.462616,"twenty":-38.638915,"median":-28.066584,"eighty":-5.578764,"marketCap":87693178287},{"date":"2020-09-25","current":-44.177192,"twenty":-39.337069,"median":-29.168327,"eighty":-5.58909,"marketCap":80974467101},{"date":"2020-09-30","current":-43.635669,"twenty":-39.577106,"median":-29.30153,"eighty":-5.589358,"marketCap":80363386427},{"date":"2020-10-09","current":-45.526878,"twenty":-40.068119,"median":-30.400474,"eighty":-5.594485,"marketCap":85053584067},{"date":"2020-10-16","current":-50.643672,"twenty":-40.933846,"median":-30.680202,"eighty":-5.627514,"marketCap":94573985247},{"date":"2020-10-23","current":-47.907898,"twenty":-41.325791,"median":-32.326031,"eighty":-5.801767,"marketCap":89603775808},{"date":"2020-10-30","current":-42.811074,"twenty":-41.735504,"median":-32.968835,"eighty":-5.84909,"marketCap":80083374628},{"date":"2020-11-06","current":-42.967789,"twenty":-42.743927,"median":-33.29142,"eighty":-5.864706,"marketCap":81316323725},{"date":"2020-11-13","current":-40.934902,"twenty":-42.378258,"median":-33.900554,"eighty":-5.91801,"marketCap":77534169133},{"date":"2020-11-20","current":-41.561739,"twenty":-42.114631,"median":-34.056118,"eighty":-5.952614,"marketCap":79215126730},{"date":"2020-11-27","current":-38.270387,"twenty":-41.89284,"median":-34.145822,"eighty":-5.961576,"marketCap":72771455944},{"date":"2020-12-04","current":-42.094411,"twenty":-41.89284,"median":-34.507897,"eighty":-5.975351,"marketCap":80618802227},{"date":"2020-12-11","current":-41.498839,"twenty":-41.89284,"median":-34.562136,"eighty":-6.024626,"marketCap":79287996630},{"date":"2020-12-18","current":-49.483759,"twenty":-42.135729,"median":-34.875798,"eighty":-6.083138,"marketCap":94697324597},{"date":"2020-12-24","current":-53.344979,"twenty":-42.79967,"median":-35.04397,"eighty":-6.115628,"marketCap":102191861381},{"date":"2020-12-31","current":-60.05736,"twenty":-43.169204,"median":-35.327908,"eighty":-6.141418,"marketCap":115097770553},{"date":"2021-01-08","current":-59.811501,"twenty":-59.909844,"median":-58.854704,"eighty":-57.04374,"marketCap":115658880952},{"date":"2021-01-15","current":-65.889833,"twenty":-65.542577,"median":-59.934431,"eighty":-58.653787,"marketCap":127231897878},{"date":"2021-01-22","current":-75.111578,"twenty":-69.798545,"median":-61.62536,"eighty":-58.836696,"marketCap":144977859301},{"date":"2021-01-29","current":-66.268267,"twenty":-70.935369,"median":-65.600453,"eighty":-58.920414,"marketCap":128966248334},{"date":"2021-02-05","current":-70.843724,"twenty":-71.160691,"median":-66.402516,"eighty":-59.472589,"marketCap":137044833867},{"date":"2021-02-11","current":-73.259421,"twenty":-72.388775,"median":-68.623378,"eighty":-59.909845,"marketCap":141921097207},{"date":"2021-02-19","current":-69.584878,"twenty":-72.910639,"median":-69.283721,"eighty":-60.353226,"marketCap":134861432372},{"date":"2021-02-26","current":-60.141164,"twenty":-72.481128,"median":-68.087003,"eighty":-60.420269,"marketCap":116302519660},{"date":"2021-03-05","current":-56.85889,"twenty":-72.0166,"median":-66.268267,"eighty":-60.074121,"marketCap":109679535123},{"date":"2021-03-12","current":-59.415349,"twenty":-71.520469,"median":-65.634307,"eighty":-59.099919,"marketCap":114410238364},{"date":"2021-03-19","current":-58.603337,"twenty":-71.014965,"median":-65.279781,"eighty":-58.980041,"marketCap":112809077267},{"date":"2021-03-26","current":-57.420101,"twenty":-70.801528,"median":-63.675052,"eighty":-58.456619,"marketCap":110043435373},{"date":"2021-04-01","current":-99.513447,"twenty":-72.111714,"median":-65.255751,"eighty":-58.603337,"marketCap":117685340607},{"date":"2021-04-09","current":-93.829103,"twenty":-73.100725,"median":-65.311073,"eighty":-58.727146,"marketCap":111207916170},{"date":"2021-04-16","current":-91.762285,"twenty":-74.85113,"median":-65.783649,"eighty":-58.836696,"marketCap":109170074775},{"date":"2021-04-23","current":-109.839824,"twenty":-90.431092,"median":-66.402516,"eighty":-58.920414,"marketCap":131004089730},{"date":"2021-04-30","current":-102.619464,"twenty":-91.452277,"median":-68.724058,"eighty":-59.011683,"marketCap":122897013046},{"date":"2021-05-07","current":-97.428671,"twenty":-96.409896,"median":-69.352117,"eighty":-59.213107,"marketCap":117436541495},{"date":"2021-05-14","current":-101.964808,"twenty":-97.632955,"median":-70.026533,"eighty":-59.379727,"marketCap":122824206759},{"date":"2021-05-21","current":-109.973218,"twenty":-99.103595,"median":-70.738235,"eighty":-59.57381,"marketCap":132507442977},{"date":"2021-05-28","current":-107.105119,"twenty":-100.222008,"median":-71.636143,"eighty":-59.909845,"marketCap":130323254356},{"date":"2021-06-04","current":-106.183195,"twenty":-103.047548,"median":-72.784205,"eighty":-60.090882,"marketCap":128588964422},{"date":"2021-06-11","current":-108.23655,"twenty":-104.283306,"median":-74.011578,"eighty":-60.308104,"marketCap":131066032292},{"date":"2021-06-18","current":-104.996815,"twenty":-104.950024,"median":-74.677498,"eighty":-60.754148,"marketCap":126111896552},{"date":"2021-06-25","current":-108.401163,"twenty":-105.285659,"median":-75.279371,"eighty":-61.553193,"marketCap":130118918107},{"date":"2021-07-02","current":-106.622678,"twenty":-106.183195,"median":-90.445668,"eighty":-61.619211,"marketCap":127760482537},{"date":"2021-07-09","current":-100.272231,"twenty":-106.183195,"median":-90.948745,"eighty":-61.62536,"marketCap":120030681653},{"date":"2021-07-16","current":-106.975494,"twenty":-106.622678,"median":-92.795694,"eighty":-61.712678,"marketCap":128052173136},{"date":"2021-07-23","current":-102.477274,"twenty":-106.622678,"median":-96.369361,"eighty":-62.277177,"marketCap":122655897047},{"date":"2021-07-30","current":-96.244101,"twenty":-106.531079,"median":-96.160202,"eighty":-62.43474,"marketCap":115582400012},{"date":"2021-08-06","current":-90.456671,"twenty":-106.183195,"median":-96.076303,"eighty":-63.026939,"marketCap":108369781827},{"date":"2021-08-13","current":-89.117798,"twenty":-106.148472,"median":-94.251891,"eighty":-64.323165,"marketCap":106911238330},{"date":"2021-08-20","current":-76.56893,"twenty":-106.141613,"median":-92.830432,"eighty":-65.231721,"marketCap":91596531611},{"date":"2021-08-27","current":-52.912902,"twenty":-105.631697,"median":-91.452399,"eighty":-63.026939,"marketCap":88752371792},{"date":"2021-09-03","current":-57.411891,"twenty":-105.383527,"median":-90.623704,"eighty":-61.62536,"marketCap":96337788726},{"date":"2021-09-10","current":-55.660683,"twenty":-105.292659,"median":-90.464692,"eighty":-60.141164,"marketCap":93639455507},{"date":"2021-09-17","current":-57.825782,"twenty":-105.258722,"median":-90.168186,"eighty":-59.326295,"marketCap":96994140050},{"date":"2021-09-24","current":-63.057451,"twenty":-105.257871,"median":-87.790274,"eighty":-59.397538,"marketCap":105818418957},{"date":"2021-09-30","current":-65.454027,"twenty":-105.205276,"median":-86.731586,"eighty":-59.427942,"marketCap":110207765023},{"date":"2021-10-08","current":-65.977203,"twenty":-105.066231,"median":-82.434007,"eighty":-59.619544,"marketCap":111083588321},{"date":"2021-10-15","current":-66.495128,"twenty":-104.917441,"median":-78.481513,"eighty":-59.76961,"marketCap":112032396894},{"date":"2021-10-22","current":-65.935102,"twenty":-104.784173,"median":-75.402004,"eighty":-59.909845,"marketCap":111886426345},{"date":"2021-10-29","current":-60.1915,"twenty":-104.573848,"median":-74.894538,"eighty":-59.969027,"marketCap":101887443690},{"date":"2021-11-05","current":-59.419571,"twenty":-104.241823,"median":-74.011578,"eighty":-59.426278,"marketCap":100746520293},{"date":"2021-11-12","current":-64.535702,"twenty":-104.144247,"median":-72.784205,"eighty":-59.558476,"marketCap":109872110899},{"date":"2021-11-19","current":-68.964255,"twenty":-103.89668,"median":-71.636143,"eighty":-59.76961,"marketCap":117245588109},{"date":"2021-11-26","current":-63.104,"twenty":-103.574286,"median":-70.738235,"eighty":-59.868596,"marketCap":107316945529},{"date":"2021-12-03","current":-56.970022,"twenty":-103.502791,"median":-69.584878,"eighty":-59.426278,"marketCap":97064410689},{"date":"2021-12-10","current":-56.787261,"twenty":-103.406584,"median":-69.317919,"eighty":-59.328306,"marketCap":96918229348},{"date":"2021-12-17","current":-46.241205,"twenty":-103.373136,"median":-68.872296,"eighty":-58.827693,"marketCap":78864833685},{"date":"2021-12-24","current":-42.300946,"twenty":-103.099197,"median":-68.604599,"eighty":-58.435519,"marketCap":72213582651},{"date":"2021-12-31","current":-41.234857,"twenty":-102.722762,"median":-67.767406,"eighty":-58.065904,"marketCap":70546743038},{"date":"2022-01-07","current":-34.486195,"twenty":-40.275969,"median":-37.64864,"eighty":-34.378339,"marketCap":58776768292},{"date":"2022-01-14","current":-37.878055,"twenty":-39.829817,"median":-37.763347,"eighty":-34.687526,"marketCap":64698308382},{"date":"2022-01-21","current":-35.699125,"twenty":-39.504145,"median":-36.722111,"eighty":-34.943651,"marketCap":61116142155},{"date":"2022-01-28","current":-26.329119,"twenty":-38.684591,"median":-35.628932,"eighty":-34.378339,"marketCap":44959841418},{"date":"2022-02-04","current":-26.846632,"twenty":-38.167145,"median":-35.414472,"eighty":-33.988231,"marketCap":45821080875},{"date":"2022-02-11","current":-27.092592,"twenty":-37.878055,"median":-35.02492,"eighty":-28.311865,"marketCap":46334276980},{"date":"2022-02-18","current":-29.050449,"twenty":-37.64864,"median":-34.653971,"eighty":-28.311865,"marketCap":49926649721},{"date":"2022-02-25","current":-29.744971,"twenty":-36.735769,"median":-33.988231,"eighty":-27.979692,"marketCap":51246296850},{"date":"2022-03-04","current":-27.223879,"twenty":-36.722111,"median":-29.802166,"eighty":-27.979692,"marketCap":46920786816},{"date":"2022-03-11","current":-23.132687,"twenty":-36.621639,"median":-29.36929,"eighty":-27.223879,"marketCap":39809355064},{"date":"2022-03-18","current":-23.353608,"twenty":-35.699125,"median":-29.07698,"eighty":-26.329119,"marketCap":40029296252},{"date":"2022-03-25","current":-23.609253,"twenty":-35.558739,"median":-28.622989,"eighty":-24.861144,"marketCap":40469178628},{"date":"2022-04-01","current":-10.302966,"twenty":-35.270205,"median":-28.485417,"eighty":-23.573298,"marketCap":39809355064},{"date":"2022-04-08","current":-10.829548,"twenty":-35.143591,"median":-28.187716,"eighty":-23.264469,"marketCap":41862139487},{"date":"2022-04-14","current":-10.543533,"twenty":-35.059727,"median":-27.88961,"eighty":-22.413734,"marketCap":40689119817},{"date":"2022-04-22","current":-10.163583,"twenty":-34.960508,"median":-27.608169,"eighty":-14.664685,"marketCap":38489707935},{"date":"2022-04-29","current":-9.896969,"twenty":-34.847033,"median":-27.171587,"eighty":-10.835566,"marketCap":36876805888},{"date":"2022-05-06","current":-7.794072,"twenty":-34.754637,"median":-27.092592,"eighty":-10.351079,"marketCap":28800028988},{"date":"2022-05-13","current":-7.531991,"twenty":-34.486195,"median":-26.329119,"eighty":-10.163583,"marketCap":27333632400},{"date":"2022-05-20","current":-9.06555,"twenty":-34.216555,"median":-24.981857,"eighty":-9.94212,"marketCap":33360522377},{"date":"2022-05-27","current":-8.694531,"twenty":-33.988231,"median":-24.386135,"eighty":-9.493302,"marketCap":31967445618},{"date":"2022-06-02","current":-9.642455,"twenty":-32.008842,"median":-23.573298,"eighty":-9.445349,"marketCap":35642983659},{"date":"2022-06-10","current":-10.68648,"twenty":-30.190287,"median":-23.325512,"eighty":-9.612624,"marketCap":39236617814},{"date":"2022-06-17","current":-10.7582,"twenty":-29.767849,"median":-23.119688,"eighty":-9.67054,"marketCap":39456636231},{"date":"2022-06-24","current":-14.400248,"twenty":-29.698416,"median":-20.893648,"eighty":-9.677673,"marketCap":53024438653},{"date":"2022-06-30","current":-13.932533,"twenty":-29.496285,"median":-17.024829,"eighty":-9.74948,"marketCap":51213898589},{"date":"2022-07-08","current":-14.67593,"twenty":-29.3239,"median":-15.17553,"eighty":-9.857114,"marketCap":54002047796},{"date":"2022-07-15","current":-14.83334,"twenty":-29.179562,"median":-14.952896,"eighty":-9.904546,"marketCap":54075420144},{"date":"2022-07-22","current":-14.019077,"twenty":-29.071673,"median":-14.83334,"eighty":-9.929111,"marketCap":51140526242},{"date":"2022-07-29","current":-13.158261,"twenty":-28.820464,"median":-14.63277,"eighty":-9.965579,"marketCap":48058887645},{"date":"2022-08-05","current":-14.452099,"twenty":-28.640649,"median":-14.521363,"eighty":-10.047766,"marketCap":52650020045},{"date":"2022-08-12","current":-14.71463,"twenty":-28.603223,"median":-14.534456,"eighty":-10.093451,"marketCap":53679489711},{"date":"2022-08-19","current":-14.001057,"twenty":-28.570837,"median":-14.521363,"eighty":-10.095676,"marketCap":50565103155},{"date":"2022-08-26","current":-15.136454,"twenty":-28.470894,"median":-14.486731,"eighty":-10.136779,"marketCap":53314867072},{"date":"2022-09-02","current":-13.75829,"twenty":-28.35224,"median":-14.400248,"eighty":-10.174316,"marketCap":48286589223},{"date":"2022-09-09","current":-12.67453,"twenty":-28.162886,"median":-14.340141,"eighty":-10.188715,"marketCap":44313642009},{"date":"2022-09-16","current":-11.97665,"twenty":-28.030016,"median":-14.29062,"eighty":-10.196162,"marketCap":41486737260},{"date":"2022-09-23","current":-10.816798,"twenty":-27.907626,"median":-14.221409,"eighty":-10.24124,"marketCap":36749761735},{"date":"2022-09-30","current":-10.989799,"twenty":-27.744526,"median":-14.086255,"eighty":-10.312544,"marketCap":37408857483},{"date":"2022-10-07","current":-10.967956,"twenty":-27.640481,"median":-14.000529,"eighty":-10.336741,"marketCap":37332356752},{"date":"2022-10-14","current":-11.448997,"twenty":-27.488229,"median":-13.89571,"eighty":-10.263806,"marketCap":38556368449},{"date":"2022-10-21","current":-13.815232,"twenty":-27.213421,"median":-13.759398,"eighty":-10.307755,"marketCap":46206441554},{"date":"2022-10-28","current":-12.395469,"twenty":-27.165938,"median":-13.60575,"eighty":-10.336584,"marketCap":41386895498},{"date":"2022-11-04","current":-14.340639,"twenty":-27.133191,"median":-13.618391,"eighty":-10.375435,"marketCap":48347495967},{"date":"2022-11-11","current":-14.799648,"twenty":-27.0434,"median":-13.75829,"eighty":-10.403849,"marketCap":50339627338},{"date":"2022-11-18","current":-14.669694,"twenty":-26.743129,"median":-13.855471,"eighty":-10.5207,"marketCap":49726663840},{"date":"2022-11-25","current":-12.759206,"twenty":-26.31944,"median":-13.760506,"eighty":-10.550481,"marketCap":42907444916},{"date":"2022-12-02","current":-12.446274,"twenty":-26.045094,"median":-13.719165,"eighty":-10.589876,"marketCap":42577469882},{"date":"2022-12-09","current":-14.33147,"twenty":-25.054285,"median":-13.649228,"eighty":-10.646322,"marketCap":49481924457},{"date":"2022-12-16","current":-14.387249,"twenty":-24.801403,"median":-13.759398,"eighty":-10.697091,"marketCap":49558640619},{"date":"2022-12-23","current":-14.560885,"twenty":-24.527177,"median":-13.788181,"eighty":-10.74327,"marketCap":50172369915},{"date":"2022-12-30","current":-14.738058,"twenty":-24.421396,"median":-13.826106,"eighty":-10.754467,"marketCap":51399828506},{"date":"2023-01-06","current":-14.850279,"twenty":-23.920006,"median":-13.912069,"eighty":-10.764544,"marketCap":52323278120},{"date":"2023-01-13","current":-18.011522,"twenty":-23.58768,"median":-13.988706,"eighty":-10.797588,"marketCap":64675254333},{"date":"2023-01-20","current":-18.576885,"twenty":-23.451175,"median":-14.010067,"eighty":-10.824448,"marketCap":66132940967},{"date":"2023-01-27","current":-20.253712,"twenty":-23.369759,"median":-14.086255,"eighty":-10.829548,"marketCap":72117128201},{"date":"2023-02-03","current":-19.550889,"twenty":-23.353608,"median":-14.221409,"eighty":-10.844594,"marketCap":69975086836},{"date":"2023-02-10","current":-18.461328,"twenty":-23.297415,"median":-14.245235,"eighty":-10.967956,"marketCap":65678370978},{"date":"2023-02-17","current":-17.287694,"twenty":-23.132687,"median":-14.283163,"eighty":-10.989799,"marketCap":60921292706},{"date":"2023-02-24","current":-16.928562,"twenty":-23.119688,"median":-14.316312,"eighty":-11.024034,"marketCap":58926388915},{"date":"2023-03-03","current":-18.506493,"twenty":-22.859931,"median":-14.340639,"eighty":-11.034338,"marketCap":64834373220},{"date":"2023-03-10","current":-17.143751,"twenty":-18.007033,"median":-17.594016,"eighty":-17.406062,"marketCap":59616932535},{"date":"2023-03-17","current":-18.225066,"twenty":-64.535702,"median":-27.223879,"eighty":-8.33302,"marketCap":63990375462},{"date":"2023-03-24","current":-16.635504,"twenty":-64.428087,"median":-27.157464,"eighty":-8.3397,"marketCap":59079843053},{"date":"2023-03-31","current":-21.665543,"twenty":-64.392731,"median":-27.092592,"eighty":-8.34275,"marketCap":53939129436},{"date":"2023-04-06","current":-23.653196,"twenty":-64.390621,"median":-26.634155,"eighty":-8.352405,"marketCap":58849661846},{"date":"2023-04-14","current":-26.320033,"twenty":-64.362795,"median":-26.324576,"eighty":-8.358879,"marketCap":65549469340},{"date":"2023-04-21","current":-23.835896,"twenty":-64.30121,"median":-26.271674,"eighty":-8.365503,"marketCap":59332248009},{"date":"2023-04-28","current":-23.269102,"twenty":-64.264448,"median":-25.584933,"eighty":-8.381733,"marketCap":57490108356},{"date":"2023-05-05","current":-25.40213,"twenty":-64.226366,"median":-25.443671,"eighty":-8.392457,"marketCap":62863015679},{"date":"2023-05-12","current":-24.841882,"twenty":-63.995645,"median":-25.285405,"eighty":-8.397793,"marketCap":61053226682},{"date":"2023-05-19","current":-24.150302,"twenty":-63.567828,"median":-25.133368,"eighty":-8.401129,"marketCap":58518941801},{"date":"2023-05-25","current":-24.040915,"twenty":-63.478503,"median":-25.133368,"eighty":-8.403051,"marketCap":57981366220},{"date":"2023-06-02","current":-23.630086,"twenty":-63.473336,"median":-25.04176,"eighty":-8.412356,"marketCap":56829418547},{"date":"2023-06-09","current":-24.154309,"twenty":-63.449017,"median":-24.911552,"eighty":-8.424162,"marketCap":58006344624},{"date":"2023-06-16","current":-23.65814,"twenty":-63.399642,"median":-24.844401,"eighty":-8.424971,"marketCap":56542705118},{"date":"2023-06-23","current":-19.736815,"twenty":-63.261636,"median":-24.800239,"eighty":-8.430589,"marketCap":46913497843},{"date":"2023-06-30","current":-19.361003,"twenty":-63.08538,"median":-24.583422,"eighty":-8.44223,"marketCap":45603925654},{"date":"2023-07-07","current":-19.824835,"twenty":-63.045246,"median":-24.39464,"eighty":-8.448328,"marketCap":46605363211},{"date":"2023-07-14","current":-20.972988,"twenty":-63.025798,"median":-24.281068,"eighty":-8.448858,"marketCap":49996366985},{"date":"2023-07-21","current":-21.298184,"twenty":-63.023861,"median":-24.205923,"eighty":-8.451759,"marketCap":50535619017},{"date":"2023-07-28","current":-23.791121,"twenty":-62.900857,"median":-24.161547,"eighty":-8.45846,"marketCap":56390355367},{"date":"2023-08-04","current":-21.285622,"twenty":-62.621827,"median":-24.152023,"eighty":-8.468652,"marketCap":50535619017},{"date":"2023-08-11","current":-21.635252,"twenty":-62.473049,"median":-24.087847,"eighty":-8.483716,"marketCap":51075672185},{"date":"2023-08-18","current":-20.673771,"twenty":-62.457914,"median":-23.929713,"eighty":-8.495975,"marketCap":48456406945},{"date":"2023-08-25","current":-35.378703,"twenty":-62.412077,"median":-24.023529,"eighty":-8.502433,"marketCap":52077155954},{"date":"2023-09-01","current":-36.587783,"twenty":-62.312576,"median":-24.142541,"eighty":-8.513294,"marketCap":54080524613},{"date":"2023-09-08","current":-37.287346,"twenty":-62.243984,"median":-24.154309,"eighty":-8.541071,"marketCap":54465713535},{"date":"2023-09-15","current":-41.061694,"twenty":-62.09617,"median":-24.166632,"eighty":-8.556024,"marketCap":60443963680},{"date":"2023-09-22","current":-41.150073,"twenty":-62.027557,"median":-24.212626,"eighty":-8.57503,"marketCap":60309214704},{"date":"2023-09-29","current":-41.957156,"twenty":-61.990984,"median":-24.362375,"eighty":-8.585232,"marketCap":61597529037},{"date":"2023-10-06","current":-42.818398,"twenty":-61.979722,"median":-24.399805,"eighty":-8.60704,"marketCap":62831819583},{"date":"2023-10-13","current":-48.929979,"twenty":-61.964165,"median":-24.604406,"eighty":-8.63324,"marketCap":71692717216},{"date":"2023-10-20","current":-48.564987,"twenty":-61.809044,"median":-24.821061,"eighty":-8.647132,"marketCap":71048288297},{"date":"2023-10-27","current":-49.577379,"twenty":-61.731951,"median":-24.852773,"eighty":-8.67951,"marketCap":72498253365},{"date":"2023-11-03","current":-50.935903,"twenty":-61.695214,"median":-24.911552,"eighty":-8.688438,"marketCap":74682635412},{"date":"2023-11-10","current":-51.497919,"twenty":-61.695214,"median":-24.911552,"eighty":-8.688438,"marketCap":75490889042},{"date":"2023-11-17","current":-48.797205,"twenty":-61.564351,"median":-24.911552,"eighty":-8.688438,"marketCap":72177049159},{"date":"2023-11-24","current":-47.423194,"twenty":-61.037754,"median":-24.911552,"eighty":-8.688438,"marketCap":70722192625},{"date":"2023-12-01","current":-47.541194,"twenty":-60.124403,"median":-24.911552,"eighty":-8.688438,"marketCap":71192149820},{"date":"2023-12-08","current":-43.123442,"twenty":-59.680613,"median":-24.911552,"eighty":-8.688438,"marketCap":64315635348},{"date":"2023-12-15","current":-45.518514,"twenty":-59.330317,"median":-24.911552,"eighty":-8.688438,"marketCap":68279743691},{"date":"2023-12-22","current":-41.339438,"twenty":-58.771185,"median":-24.911552,"eighty":-8.688438,"marketCap":61969530411},{"date":"2023-12-29","current":-45.897864,"twenty":-58.451098,"median":-24.911552,"eighty":-8.688438,"marketCap":69169645563},{"date":"2024-01-05","current":-41.6186,"twenty":-58.024001,"median":-24.911552,"eighty":-8.688438,"marketCap":62278306752},{"date":"2024-01-12","current":-43.437966,"twenty":-57.418459,"median":-24.911552,"eighty":-8.688438,"marketCap":65035419290},{"date":"2024-01-19","current":-39.267262,"twenty":-56.725823,"median":-24.911552,"eighty":-8.688438,"marketCap":58710278761},{"date":"2024-01-26","current":-36.31712,"twenty":-55.836725,"median":-24.911552,"eighty":-8.688438,"marketCap":54088060681},{"date":"2024-02-02","current":-34.853132,"twenty":-55.005219,"median":-24.911552,"eighty":-8.688438,"marketCap":51841523559},{"date":"2024-02-09","current":-39.078682,"twenty":-54.567045,"median":-24.977375,"eighty":-8.690942,"marketCap":58412984292},{"date":"2024-02-16","current":-43.519901,"twenty":-53.86795,"median":-24.961961,"eighty":-8.689273,"marketCap":65065574169},{"date":"2024-02-23","current":-43.423228,"twenty":-53.453001,"median":-24.961961,"eighty":-8.689273,"marketCap":64578799300},{"date":"2024-03-01","current":-43.287126,"twenty":-53.199825,"median":-24.969668,"eighty":-8.690107,"marketCap":64416541010},{"date":"2024-03-08","current":-42.88643,"twenty":-52.44341,"median":-24.969668,"eighty":-8.690107,"marketCap":63848636996},{"date":"2024-03-15","current":-46.524187,"twenty":-51.488905,"median":-25.009567,"eighty":-8.693429,"marketCap":69203160557},{"date":"2024-03-22","current":-52.308694,"twenty":-51.849485,"median":-25.232473,"eighty":-8.716682,"marketCap":58412984292},{"date":"2024-03-28","current":-54.97427,"twenty":-52.93553,"median":-25.488194,"eighty":-8.784794,"marketCap":61171375216},{"date":"2024-04-05","current":-52.146452,"twenty":-52.985136,"median":-25.87886,"eighty":-8.870004,"marketCap":58007338567},{"date":"2024-04-12","current":-54.452719,"twenty":-53.302804,"median":-26.375398,"eighty":-8.942783,"marketCap":60607206202},{"date":"2024-04-19","current":-48.443774,"twenty":-53.302804,"median":-27.157464,"eighty":-9.068996,"marketCap":53873072180},{"date":"2024-04-26","current":-57.196236,"twenty":-53.435518,"median":-27.450523,"eighty":-9.167423,"marketCap":63528035417},{"date":"2024-05-03","current":-59.794233,"twenty":-53.777852,"median":-27.730775,"eighty":-9.397396,"marketCap":66367730487},{"date":"2024-05-10","current":-60.546292,"twenty":-54.435313,"median":-28.113255,"eighty":-9.857114,"marketCap":67362014561},{"date":"2024-05-17","current":-58.658055,"twenty":-54.574873,"median":-28.485417,"eighty":-9.977493,"marketCap":65165427130},{"date":"2024-05-24","current":-52.700238,"twenty":-54.976338,"median":-29.07698,"eighty":-10.139927,"marketCap":58412954655},{"date":"2024-05-31","current":-51.620118,"twenty":-54.976338,"median":-29.361089,"eighty":-10.283386,"marketCap":57273983395},{"date":"2024-06-07","current":-52.565196,"twenty":-54.976338,"median":-30.241673,"eighty":-10.532117,"marketCap":58250244475},{"date":"2024-06-14","current":-56.319381,"twenty":-54.981036,"median":-31.054417,"eighty":-10.718314,"marketCap":62353269027},{"date":"2024-06-21","current":-54.227183,"twenty":-55.099632,"median":-32.881149,"eighty":-10.838576,"marketCap":59911234992},{"date":"2024-06-28","current":-54.249689,"twenty":-55.440028,"median":-33.56094,"eighty":-11.097775,"marketCap":59911234992},{"date":"2024-07-05","current":-58.463788,"twenty":-55.657871,"median":-34.005125,"eighty":-11.220642,"marketCap":64551099658},{"date":"2024-07-12","current":-59.938373,"twenty":-55.745963,"median":-34.181189,"eighty":-11.407271,"marketCap":66276432299},{"date":"2024-07-19","current":-59.716353,"twenty":-55.97848,"median":-34.545269,"eighty":-11.738708,"marketCap":66032170263},{"date":"2024-07-26","current":-57.074426,"twenty":-56.131334,"median":-34.806278,"eighty":-12.250774,"marketCap":63345287873},{"date":"2024-08-02","current":-57.621526,"twenty":-56.307104,"median":-34.994572,"eighty":-12.425719,"marketCap":63915232622},{"date":"2024-08-09","current":-60.772336,"twenty":-56.714024,"median":-35.324454,"eighty":-12.694151,"marketCap":67859465726},{"date":"2024-08-16","current":-59.654815,"twenty":-57.048523,"median":-35.648167,"eighty":-12.850581,"marketCap":66637506560},{"date":"2024-08-23","current":-63.107395,"twenty":-57.458873,"median":-35.962733,"eighty":-13.047453,"marketCap":70792167727},{"date":"2024-08-30","current":-49.12916,"twenty":-57.66299,"median":-36.345755,"eighty":-13.206187,"marketCap":69162888838},{"date":"2024-09-06","current":-49.915263,"twenty":-57.66299,"median":-36.567164,"eighty":-13.37092,"marketCap":70303384060},{"date":"2024-09-13","current":-51.145513,"twenty":-57.66299,"median":-36.671875,"eighty":-13.573848,"marketCap":71847570529},{"date":"2024-09-20","current":-49.167101,"twenty":-57.683721,"median":-36.986342,"eighty":-13.63831,"marketCap":69482554019},{"date":"2024-09-27","current":-53.462204,"twenty":-57.683721,"median":-37.445773,"eighty":-13.783867,"marketCap":76006737495},{"date":"2024-10-04","current":-58.949991,"twenty":-57.776104,"median":-37.558101,"eighty":-13.908798,"marketCap":83427996199},{"date":"2024-10-10","current":-56.643507,"twenty":-57.816343,"median":-37.60917,"eighty":-13.995484,"marketCap":79676590700},{"date":"2024-10-18","current":-54.316933,"twenty":-57.819489,"median":-37.924768,"eighty":-14.224435,"marketCap":75975160467},{"date":"2024-10-25","current":-51.747614,"twenty":-57.819489,"median":-38.255535,"eighty":-14.2894,"marketCap":72376767507},{"date":"2024-11-01","current":-40.961176,"twenty":-57.819489,"median":-38.986697,"eighty":-14.340877,"marketCap":57328942398},{"date":"2024-11-08","current":-45.608937,"twenty":-57.819489,"median":-39.308677,"eighty":-14.420988,"marketCap":63544348421},{"date":"2024-11-15","current":-44.200719,"twenty":-57.819489,"median":-39.497388,"eighty":-14.54548,"marketCap":60930246271},{"date":"2024-11-22","current":-43.988394,"twenty":-57.819489,"median":-39.586206,"eighty":-14.672188,"marketCap":60602664302},{"date":"2024-11-29","current":-45.857239,"twenty":-57.819489,"median":-39.778153,"eighty":-14.785857,"marketCap":63141424563},{"date":"2024-12-06","current":-45.071237,"twenty":-57.819489,"median":-40.220709,"eighty":-14.848685,"marketCap":61912992178},{"date":"2024-12-13","current":-44.682481,"twenty":-57.819489,"median":-40.576246,"eighty":-15.014493,"marketCap":61257828240},{"date":"2024-12-20","current":-42.241276,"twenty":-57.819489,"median":-40.934902,"eighty":-15.254477,"marketCap":57654426579},{"date":"2024-12-27","current":-42.754459,"twenty":-57.819489,"median":-40.969369,"eighty":-15.339213,"marketCap":58309590517},{"date":"2025-01-03","current":-42.534452,"twenty":-57.819489,"median":-41.085429,"eighty":-15.481309,"marketCap":58066335414},{"date":"2025-01-10","current":-40.407856,"twenty":-57.819489,"median":-41.176668,"eighty":-16.193782,"marketCap":54954176393},{"date":"2025-01-17","current":-37.851954,"twenty":-57.819489,"median":-41.179186,"eighty":-16.682563,"marketCap":51519723275},{"date":"2025-01-24","current":-38.69271,"twenty":-57.819489,"median":-41.179186,"eighty":-16.915608,"marketCap":52994055579},{"date":"2025-01-28","current":-39.34211,"twenty":-57.816343,"median":-41.177927,"eighty":-16.989137,"marketCap":54140758482},{"date":"2025-02-07","current":-43.376749,"twenty":-57.822636,"median":-41.225174,"eighty":-17.320246,"marketCap":59382828895},{"date":"2025-02-14","current":-44.895241,"twenty":-57.822636,"median":-41.439791,"eighty":-17.61594,"marketCap":61432031400},{"date":"2025-02-21","current":-49.746076,"twenty":-57.822636,"median":-41.616926,"eighty":-17.999791,"marketCap":68312418916},{"date":"2025-02-28","current":-48.414447,"twenty":-57.822636,"median":-41.739825,"eighty":-18.237812,"marketCap":66264684536},{"date":"2025-03-07","current":-47.922812,"twenty":-57.825782,"median":-42.027254,"eighty":-18.551688,"marketCap":65855137660},{"date":"2025-03-14","current":-48.79914,"twenty":-57.825782,"median":-42.125115,"eighty":-18.662738,"marketCap":67083778288},{"date":"2025-03-21","current":-48.401057,"twenty":-57.825782,"median":-42.299167,"eighty":-18.935846,"marketCap":66510412662},{"date":"2025-03-28","current":-55.188745,"twenty":-57.825782,"median":-42.496478,"eighty":-19.437399,"marketCap":75684262684},{"date":"2025-04-03","current":-812.530138,"twenty":-57.971959,"median":-42.563523,"eighty":-19.437399,"marketCap":82318922076},{"date":"2025-04-11","current":-779.078321,"twenty":-58.17521,"median":-42.754459,"eighty":-19.437399,"marketCap":78223453316},{"date":"2025-04-17","current":-769.900239,"twenty":-58.259802,"median":-42.852414,"eighty":-19.446154,"marketCap":77404359564},{"date":"2025-04-25","current":-889.264014,"twenty":-58.573908,"median":-42.97387,"eighty":-19.435927,"marketCap":89578154558},{"date":"2025-05-02","current":-896.357794,"twenty":-58.735668,"median":-42.988967,"eighty":-19.437399,"marketCap":90484649223},{"date":"2025-05-09","current":-849.575932,"twenty":-58.959846,"median":-43.1845,"eighty":-19.435927,"marketCap":86364218930},{"date":"2025-05-16","current":-820.85164,"twenty":-59.318718,"median":-43.369817,"eighty":-19.435927,"marketCap":84125961099},{"date":"2025-05-23","current":-940.361806,"twenty":-59.416193,"median":-43.416299,"eighty":-19.435927,"marketCap":96662378831},{"date":"2025-05-30","current":-989.768217,"twenty":-59.721419,"median":-43.519443,"eighty":-19.435927,"marketCap":102188299805},{"date":"2025-06-06","current":-1165.735261,"twenty":-59.85563,"median":-43.586357,"eighty":-19.435927,"marketCap":120663020674},{"date":"2025-06-13","current":-1287.14885,"twenty":-60.074121,"median":-43.654071,"eighty":-19.435927,"marketCap":133282988343},{"date":"2025-06-20","current":-1241.733329,"twenty":-60.490073,"median":-43.829003,"eighty":-19.435927,"marketCap":128328230412},{"date":"2025-06-27","current":-1232.687947,"twenty":-60.772336,"median":-43.882417,"eighty":-19.437399,"marketCap":127750175320},{"date":"2025-06-30","current":-1248.706528,"twenty":-60.856179,"median":-43.894007,"eighty":-19.437399,"marketCap":129484340596}],"updateTime":1751359960040}}}